PARP11 inhibitor ITK7
|
P647098-25mg
|
|
2411890-36-1 |
25mg
|
¥ 12500.9
|
期货,请咨询 |
阿拉丁 |
PARP11 inhibitor ITK7
|
P647098-10mg
|
|
2411890-36-1 |
10mg
|
¥ 6200.9
|
期货,请咨询 |
阿拉丁 |
PROTAC FLT-3 degrader 1
|
P647097-5mg
|
≥99% |
2230826-81-8 |
5mg
|
¥ 20000.9
|
期货,请咨询 |
阿拉丁 |
PROTAC FLT-3 degrader 1
|
P647097-1mg
|
≥99% |
2230826-81-8 |
1mg
|
¥ 7800.9
|
期货,请咨询 |
阿拉丁 |
PROTAC FLT-3 degrader 1
|
P647097-10mg
|
≥99% |
2230826-81-8 |
10mg
|
¥ 32000.9
|
期货,请咨询 |
阿拉丁 |
Purpureaside C
|
P647076-5mg
|
≥99% |
108648-07-3 |
5mg
|
¥ 5700.9
|
期货,请咨询 |
阿拉丁 |
Purpureaside C
|
P647076-1mg
|
≥99% |
108648-07-3 |
1mg
|
¥ 2500.9
|
期货,请咨询 |
阿拉丁 |
Purpureaside C
|
P647076-10mg
|
≥99% |
108648-07-3 |
10mg
|
¥ 7900.9
|
期货,请咨询 |
阿拉丁 |
PF-07220060
|
P647066-5mg
|
≥99% |
2380321-51-5 |
5mg
|
¥ 3000.9
|
期货,请咨询 |
阿拉丁 |
PF-07220060
|
P647066-50mg
|
≥99% |
2380321-51-5 |
50mg
|
¥ 13500.9
|
期货,请咨询 |
阿拉丁 |
PF-07220060
|
P647066-25mg
|
≥99% |
2380321-51-5 |
25mg
|
¥ 9100.9
|
期货,请咨询 |
阿拉丁 |
PF-07220060
|
P647066-1mg
|
≥99% |
2380321-51-5 |
1mg
|
¥ 1142.9
|
期货,请咨询 |
阿拉丁 |
PF-07220060
|
P647066-10mg
|
≥99% |
2380321-51-5 |
10mg
|
¥ 4800.9
|
期货,请咨询 |
阿拉丁 |
PS10
|
P647045-5mg
|
≥99% |
1564265-82-2 |
5mg
|
¥ 1000.9
|
期货,请咨询 |
阿拉丁 |
PS10
|
P647045-50mg
|
≥99% |
1564265-82-2 |
50mg
|
¥ 6700.9
|
期货,请咨询 |
阿拉丁 |
PS10
|
P647045-10mg
|
≥99% |
1564265-82-2 |
10mg
|
¥ 1800.9
|
期货,请咨询 |
阿拉丁 |
PS10
|
P647045-100mg
|
≥99% |
1564265-82-2 |
100mg
|
¥ 11000.9
|
期货,请咨询 |
阿拉丁 |
Peldesine
|
P647043-5mg
|
|
133432-71-0 |
5mg
|
¥ 3500.9
|
期货,请咨询 |
阿拉丁 |
Peldesine
|
P647043-10mg
|
|
133432-71-0 |
10mg
|
¥ 5600.9
|
期货,请咨询 |
阿拉丁 |
Pterosin B
|
P647021-5mg
|
≥99% |
34175-96-7 |
5mg
|
¥ 4200.9
|
期货,请咨询 |
阿拉丁 |
Pterosin B
|
P647021-1mg
|
≥99% |
34175-96-7 |
1mg
|
¥ 1450.9
|
期货,请咨询 |
阿拉丁 |
Pterosin B
|
P647021-10mg
|
≥99% |
34175-96-7 |
10mg
|
¥ 6200.9
|
期货,请咨询 |
阿拉丁 |
Pimonidazole hydrochloride
|
P646989-50mg
|
Moligand™, ≥99% |
70132-51-3 |
50mg
|
¥ 1599.9
|
现货 |
阿拉丁 |
Pimonidazole hydrochloride
|
P646989-10mg
|
Moligand™, ≥99% |
70132-51-3 |
10mg
|
¥ 399.9
|
现货 |
阿拉丁 |